Sophia is the co-founder of True's global Life Sciences practice and now co-leads True's Healthcare & Life Sciences practices in EMEA & APAC specializing in biotech & pharma, life science tools / techbio, diagnostics and medtech.  She was the chief growth officer / member of the executive team of an ARCH backed San Diego / Oxford biotech, leading HR, talent and investor relations where she successfully built out the company's US presence, organizational structure, trans-atlantic leadership and board. ​

Prior to True, Sophia was a key member of the global healthcare practice at Russell Reynolds Associates placing executives and building boards across Fortune / FTSE 100 companies to ground breaking startups pioneering transformational technologies.  She has placed more than 200 executives / board appointments including VC and PE-backed companies that have since gone through a successful exit. ​

Sophia is a published scientist, she holds a first class master’s degree from University College London in natural sciences, specializing in cell and molecular biology.  She was nominated for the European Science Engineering and Technology Awards for her discovery of novel anti-cancer and anti-aging therapeutic targets and won an MRC-funded scholarship in translational oncology at Imperial College London, using CRISPR / Cas9 genetic editing technology. ​

​Sophia's experience as an operator, investor, scientist and search professional has helped her to develop a novel and advisory approach to executive search.  She is a founding member of Chief in the UK, one of the largest private executive networks supporting female leadership.  She is also a venture advisory partner to a healthtech fund with the aim of supporting DE&I in founders.